Copyright
©The Author(s) 2025.
World J Diabetes. Aug 15, 2025; 16(8): 106833
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.106833
Published online Aug 15, 2025. doi: 10.4239/wjd.v16.i8.106833
Figure 5 The expression of calcineurin was upregulated and the expression of p- dynamin-related protein 1ser637was downregulated in hippocampus of diabetic cognitive dysfunction mice.
A: The normalized mRNA expression of calcineurin (CaN); B: Protein bands of CaN, T-dynamin-related protein 1 (Drp1), and p-Drp1ser637; C: The relative protein expression of CaN, T-Drp1, and p-Drp1ser637; D: Immunofluorescent staining of CaN; E: Immunofluorescent staining of p-Drp1ser637. aP < 0.05, compared with dm group. Data presented as mean ± SEM. Drp1: Dynamin-related protein 1; dm: Control group; db: Diabetes group; CaN: Calcineurin; DAPI: 4’,6-diamidino-2-phenylindole.
- Citation: Li J, Gao M, Wang JX, Li HY, Wang P, Yuan F, Liu AJ, Zhang SY. Troxerutin improves diabetic cognitive dysfunction by inhibiting mitochondrial fission mediated by transient receptor potential melastatin 7/calcineurin/dynamin-related protein 1ser637. World J Diabetes 2025; 16(8): 106833
- URL: https://www.wjgnet.com/1948-9358/full/v16/i8/106833.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i8.106833